[TruScreen Combined With High-Risk Human Papillomavirus Testing vs Thinprep Cytology Test Combined With High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: A Comparative Clinical Study].
Year: 2025
Type: article
Abstract: Objective: To compare the clinical value of TruScreen, an artificial intelligence-based real-time cervical cancer screening system, combined with high-risk human papillomavirus (hr-HPV) test and Thinprep cytology test (TCT) combined with hr-HPV test in cervical cancer screening. Methods: ) cervical lesions was evaluated. Results: < 0.05). Conclusion: TruScreen combined with hr-HPV test demonstrates superior performance in cervical cancer screening compared with TCT combined with hr-HPV test. TruScreen combined with hr-HPV test may serve as an alternative to conventional cytology-based methods for cervical cancer screening in China.
Source: PubMed
DOI: 10.12182/20250560609
Authors: Yi Yang, Chunmei Li, Shuyun Jia, Yifeng Wang, Dengpan Wang, Liyin Zhang
Institutions: Panzhihua University, Panzhihua Central Hospital
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4414341571
FWCI:
Cites:
Cited by:
Related to: